Correlation Between Sprint Bioscience and XMReality
Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and XMReality at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and XMReality into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprint Bioscience AB and XMReality AB, you can compare the effects of market volatilities on Sprint Bioscience and XMReality and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of XMReality. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and XMReality.
Diversification Opportunities for Sprint Bioscience and XMReality
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sprint and XMReality is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and XMReality AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XMReality AB and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with XMReality. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XMReality AB has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and XMReality go up and down completely randomly.
Pair Corralation between Sprint Bioscience and XMReality
Assuming the 90 days trading horizon Sprint Bioscience AB is expected to generate 0.34 times more return on investment than XMReality. However, Sprint Bioscience AB is 2.93 times less risky than XMReality. It trades about 0.09 of its potential returns per unit of risk. XMReality AB is currently generating about -0.08 per unit of risk. If you would invest 125.00 in Sprint Bioscience AB on September 1, 2024 and sell it today you would earn a total of 57.00 from holding Sprint Bioscience AB or generate 45.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.22% |
| Values | Daily Returns |
Sprint Bioscience AB vs. XMReality AB
Performance |
| Timeline |
| Sprint Bioscience |
| XMReality AB |
Sprint Bioscience and XMReality Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sprint Bioscience and XMReality
The main advantage of trading using opposite Sprint Bioscience and XMReality positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, XMReality can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XMReality will offset losses from the drop in XMReality's long position.| Sprint Bioscience vs. Kancera AB | Sprint Bioscience vs. Cyxone AB | Sprint Bioscience vs. Lidds AB | Sprint Bioscience vs. Cantargia AB |
| XMReality vs. Tangiamo Touch Technology | XMReality vs. Zaplox AB | XMReality vs. Alligator Bioscience AB | XMReality vs. Garo AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |